Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study  Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,

Published byWilliam Noah Nichols Modified over 6 years ago

Similar presentations

Presentation on theme: "Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study  Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,"— Presentation transcript:

1 Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study 
Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng, Paola Simona Ravenda, MD, Elena Magni, MD, Monica Casiraghi, MD, Piergiorgio Solli, MD, Francesco Petrella, MD, Roberto Gasparri, MD, Domenico Galetta, MD, PhD, Alessandro Borri, MD, Stefano Donghi, MD, Giulia Veronesi, MD, Lorenzo Spaggiari, MD, PhD  The Annals of Thoracic Surgery  Volume 98, Issue 4, Pages (October 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival (A) after a first pulmonary metastasectomy overall, and (B) according to radicality of surgery. (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall survival after a first R0 pulmonary metastasectomy according to selected patient characteristics: (A) stage of primary cancer; (B) disease-free interval; (C) number of metastases; (D) adjuvant chemotherapy (CT); and (E) hilar/mediastinal nodal status. (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Overall survival after a first R0 pulmonary metastasectomy according to biomarkers: (A) carcinoembryonic antigen, and (B) K-RAS. (CI = confidence interval; Mut = mutation; WT = wild-type.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Overall survival after a first R0 pulmonary metastasectomy according to use of chemotherapy. (CI = confidence interval; Post = postoperative; Pre = preoperative.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study  Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,"

Similar presentations

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy  Antonio Mazzella, MD, Alessandro Pardolesi,

Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy  Antonio Mazzella, MD, Alessandro Pardolesi,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,
Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?  Francesco Leo, MD, Piergiorgio Solli,

Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?  Francesco Leo, MD, Piergiorgio Solli,
Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Radio-Guided Localization and Resection of Small or Ill-Defined Pulmonary Lesions  Domenico Galetta, MD, PhD, Massimo Bellomi, MD, Chiara Grana, MD, Lorenzo.

Radio-Guided Localization and Resection of Small or Ill-Defined Pulmonary Lesions  Domenico Galetta, MD, PhD, Massimo Bellomi, MD, Chiara Grana, MD, Lorenzo.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy  Francesco Petrella, MD, Davide Radice,

Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy  Francesco Petrella, MD, Davide Radice,
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Factors Predicting Recurrence and Postrecurrence Survival in Completely Resected Thymic Carcinoma  Yi-Ting Yen, MD, Wu-Wei Lai, MD, Kai-Wei Chang, MD,

Factors Predicting Recurrence and Postrecurrence Survival in Completely Resected Thymic Carcinoma  Yi-Ting Yen, MD, Wu-Wei Lai, MD, Kai-Wei Chang, MD,
Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D
Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,

Similar presentations

Ads by Google